VUM02

· Wuhan Optics Valley Vcanbiopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VUM02, covering 2024-11-06 to 2024-11-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) Treatment [Phase 1, Phase 2]

See pricing